Hedge fund Citadel takes short position in GSK, FT reports
Billionaire Ken Griffin's hedge fund Citadel has taken a short position in British drugmaker GSK , the Financial Times ...
Hosted on MSN10mon
Naked Short Selling? Citadel Says DJT Stock CEO Devin Nunes Is Just a ‘Loser.’
But now Citadel itself is taking aim at Trump Media & Technology Group (NASDAQ:DJT) stock. Citadel Securities recently responded to TMTG CEO Devin Nunes’ claims of market manipulation.
Citadel takes $384.5 million short position in GSK - FT
Citadel, the hedge fund owned by billionaire Ken Griffin, has taken a short position in GlaxoSmithKline (NYSE:GSK), a British ...